HFB200604 AID

N/A

Report date: 2024/11/06 09:24:28

Base Information

Drug NameHFB200604 AID
Drug Alias NameHFB200604 AIDHFB-200604-AIDHFB200604HFB-200604
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionB- and T-lymphocyte attenuator agonists
TargetsB- and T-lymphocyte attenuator
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesHiFiBiO Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesHiFiBiO Therapeutics
Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A